•
AM
AMLX
Amylyx Pharmaceuticals, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
1.86B
Volume
3.57M
52W High
$17.20
52W Low
$2.60
Open
$0.00
Prev Close
$16.55
Day Range
0.00 - 0.00
About Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.
Latest News
Antisense Oligonucleotide Therapeutics Clinical Trial Pipeline Appears Robust With 70+ Key Pharma Companies Actively Working in the Domain | DelveInsight
GlobeNewswire Inc.•Aug 28
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc.•Jul 14
AMYLYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Amylyx Pharmaceuticals, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
GlobeNewswire Inc.•Jul 8
Why Amylyx Pharmaceuticals Stock Was So Healthy This Week
The Motley Fool•Oct 18
Breaking Down Amylyx Pharma: 9 Analysts Share Their Views
Benzinga•May 10
Amylyx Pharmaceuticals, Inc. (AMLX) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research•May 9
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Zacks Investment Research•Apr 12
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
Zacks Investment Research•Apr 10